88 related articles for article (PubMed ID: 12151897)
21. Factors regulating the metastatic potential of benign giant cell tumour of bone--study of an unusual case with short review of literature.
Mondal A; Kundu R; Misra DK
Indian J Pathol Microbiol; 2001 Jan; 44(1):31-5. PubMed ID: 12561992
[TBL] [Abstract][Full Text] [Related]
22. Giant cell tumour of bone with pulmonary metastases. A report of three cases.
Sanjay BK; Kadhi SM
Int Orthop; 1998; 22(3):200-4. PubMed ID: 9728318
[TBL] [Abstract][Full Text] [Related]
23. A rare case of giant cell tumour (GCT) of bone with lung metastases.
Sachan DK; Bansal N; Gupta S; Kumar S
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29326370
[TBL] [Abstract][Full Text] [Related]
24. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
[TBL] [Abstract][Full Text] [Related]
26. Benign giant cell tumor of the spine: an unusual indication for radiotherapy.
Meyer A; Bastian L; Bruns F
Arch Orthop Trauma Surg; 2006 Oct; 126(8):517-21. PubMed ID: 16810546
[TBL] [Abstract][Full Text] [Related]
27. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
28. Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial.
Bölling T; Schuck A; Paulussen M; Dirksen U; Ranft A; Könemann S; Dunst J; Willich N; Jürgens H
Strahlenther Onkol; 2008 Apr; 184(4):193-7. PubMed ID: 18398583
[TBL] [Abstract][Full Text] [Related]
29. Benign giant cell tumour of bone in a child with pulmonary metastases at presentation.
Ashraf MS; Gururangan S; Breatnach F
Eur J Surg Oncol; 1994 Dec; 20(6):700-2. PubMed ID: 7995428
[TBL] [Abstract][Full Text] [Related]
30. [Giant-cell tumor of the patella with lung metastases: a case report].
Bahri I; Ben Yahia N; Boudawara T; Makni S; Fakhfakh B; Kechaou S; Keskes H; Jlidi R
Rev Chir Orthop Reparatrice Appar Mot; 2003 Jun; 89(4):361-6. PubMed ID: 12844041
[TBL] [Abstract][Full Text] [Related]
31. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
32. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
33. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
[TBL] [Abstract][Full Text] [Related]
34. Aggressive clinical course of giant cell tumor arising from thoracic vertebra after a long latent period.
Takahashi T; Katano S; Ishikawa H; Nakano T
Radiat Med; 2006 Aug; 24(7):534-7. PubMed ID: 17058150
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results.
Graham MV; Pajak TE; Herskovic AM; Emami B; Perez CA
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):819-25. PubMed ID: 7860394
[TBL] [Abstract][Full Text] [Related]
36. [Results of whole lung irradiation and chemotherapy in comparison with partial lung irradiation in metastasizing, undifferentiated soft tissue sarcomas].
Zamboglou N; Fürst G; Pape H; Bannach B; Molls M; Schmitt G
Strahlenther Onkol; 1988 Jul; 164(7):386-92. PubMed ID: 3400046
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary metastasis of benign giant cell tumor of bone. Six histologically confirmed cases, including one of spontaneous regression.
Kay RM; Eckardt JJ; Seeger LL; Mirra JM; Hak DJ
Clin Orthop Relat Res; 1994 May; (302):219-30. PubMed ID: 8168305
[TBL] [Abstract][Full Text] [Related]
38. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
39. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
